Dual Roles of Metal–Organic Frameworks as Nanocarriers for miRNA Delivery and Adjuvants for Chemodynamic Therapy

Citations Over TimeTop 10% of 2021 papers

Abstract

MicroRNA (miRNA) represents a promising class of therapeutic nucleic acid drugs, while delivery challenges remain that impede the advancement of miRNA therapy, largely because of in vivo instability and low delivery efficiency. Herein, we discover the dual roles of metal-organic framework (MOF) nanoparticles (ZIF-8) as nanocarriers for miRNA delivery and adjuvants for chemodynamic therapy. The miR-34a-m@ZIF-8 complex demonstrated efficient cellular uptake and lysosomal stimuli-responsive miRNA release. Zn2+ triggered the generation of reactive oxygen species, which consequently induced apoptosis of tumor cells. Released miR-34a-m led to a remarkable decrease in expression of Bcl-2 at both mRNA and protein levels and enhanced cancer cell apoptosis. In vivo experiments showed high efficacy of using miR-34a-m@ZIF-8 to suppress tumor growth via synergistic gene/chemodynamic therapy in a mouse model of triple-negative breast cancer. Our work demonstrates MOFs as a promising nanoplatform for efficient synergetic gene/chemodynamic therapy.

Related Papers

• → Microbubble-enhanced ultrasound for vascular gene delivery(2000)339 cited
• → Bacteria in gene therapy: bactofection versus alternative gene therapy(2005)101 cited
• Advanced gene delivery : from concepts to pharmaceutical products(1999)
• Targeting of drugs 5 : strategies for oligonucleotide and gene delivery in therapy(1996)
• → Gene therapy for cardiovascular applications(2005)